FibroGen
FGEN
FGEN
207 hedge funds and large institutions have $2.67B invested in FibroGen in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
3% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 70
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
6% less capital invested
Capital invested by funds: $2.84B → $2.67B (-$168M)
Holders
207
Holding in Top 10
3
Calls
$50.5M
Puts
$34.4M
Top Buyers
| 1 | +$79.5M | |
| 2 | +$14.1M | |
| 3 | +$13.5M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$13.3M |
| 5 |
Morgan Stanley
New York
|
+$9.92M |
Top Sellers
| 1 | -$26M | |
| 2 | -$12.9M | |
| 3 | -$9.38M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.29M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.15M |